- Home
- Life Sciences
- Nanotechnology in Medical Devices
Nanotechnology In Medical Devices Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.
-
Published date -30th Jan 2024
-
Formats -PDF, CSV
-
Region -Global
Nanotechnology In Medical Devices Market
Market Size & CAGR in 2021
The global nanotechnology in medical devices market is expected to have a growth rate of 5.2% CAGR from 2021 to 2025. The market is anticipated to reach USD 12.5 billion by 2025.
COVID-19 Impact
The COVID-19 pandemic has significantly impacted the nanotechnology in medical devices market. The disruptions in the supply chain, reduced investments in research, and development activities have affected the market growth.
Market Dynamics
The increasing prevalence of chronic diseases, advancements in nanotechnology, and rising demand for minimally invasive procedures are driving the growth of the nanotechnology in medical devices market.
Segments and Analysis
Based on the application, the therapeutics segment dominated the market share in 2021. The diagnostics segment is expected to witness significant growth during the forecast period.
By Region Analysis
North America held the largest market share in 2021, followed by Europe and Asia Pacific. The expanding healthcare infrastructure and technological advancements in these regions contribute to market growth.
Key Market Players
Some of the key players in the nanotechnology in medical devices market include Abbott Laboratories, Stryker Corporation, and Johnson & Johnson. These players focus on strategic partnerships and product innovations to maintain their market position.
Recent Happenings
In recent developments, Abbott Laboratories launched a new nanotechnology-enabled medical device for diabetic patients. This device revolutionizes glucose monitoring with its accuracy and convenience.
